Heartflow Inc
NASDAQ:HTFL
Heartflow Inc
Research & Development
Heartflow Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Heartflow Inc
NASDAQ:HTFL
|
Research & Development
-43.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$750.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-29%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$108.6m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$93m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Research & Development
-$88.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Research & Development
-$48.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Heartflow Inc
Glance View
Heartflow Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Mountain View, California. The company went IPO on 2025-08-08. HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
See Also
What is Heartflow Inc's Research & Development?
Research & Development
-43.5m
Based on the financial report for Dec 31, 2024, Heartflow Inc's Research & Development amounts to -43.5m .
What is Heartflow Inc's Research & Development growth rate?
Research & Development CAGR 1Y
-21%
Over the last year, the Research & Development growth was -21%.
